Michael Y.Fu

Associate

アーバイン + 1.949.553.7519

Connect:

共有

Michael Fu advises public and private companies on corporate law matters. He has represented clients in domestic and cross-border mergers and acquisitions, venture capital and growth financings, and other strategic transactions. In addition, he has experience advising companies on corporate governance and compliance matters.

Michael represents public companies, middle-market private companies, and start-up companies alike and is most active in the technology (including fintech, software, and semiconductor), automotive, life sciences, health care, energy, and real estate industries. Representative matters include Astellas Pharma's $5.9 billion acquisition of Iveric Bio, Meridian Bioscience's $1.53 billion sale to SD Biosensor and SJL Partners, and Reneo Pharmaceuticals' reverse merger and concurrent PIPE (private investment in public equity) investment with OnKure. Other representations include transactions involving Five9, NGK Spark Plugs, Intel, Horizon Global, Organon, Sempra Energy, and NerdWallet. In addition, Michael completed a client secondment in the legal department of a multinational automobile manufacturer, where he advised on data privacy issues and regulatory compliance matters.

Michael also maintains an active pro bono practice, assisting nonprofits in their corporate governance matters and representing survivors of human trafficking in acquiring various forms of relief.

担当案件

  • Reneo Pharmaceuticals announces reverse merger with OnKureJones Day represented Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) in an all-stock reverse merger between Reneo and OnKure, Inc., a privately-held, clinical-stage biopharmaceutical company valued at $170 million that is focused on the development of novel precision medicines in oncology.
  • Five9 acquires AcqueonJones Day advised Five9, Inc. in its acquisition of Acqueon, a pioneering real-time revenue execution platform, realizing Five9's ambition to become the orchestration engine for every interaction across the entire customer journey, including marketing, e-commerce, sales and customer service through AI-driven, omnichannel proactive customer engagement.
  • Silicon Mobility sold to IntelJones Day advised Silicon Mobility SAS in the acquisition of the company by Intel Corporation.
  • VSE acquires assets and license from HoneywellJones Day advised VSE Corporation in the $105 million asset purchase and perpetual license agreement to manufacture and support certain of Honeywell International’s fuel control systems on four key engine platforms.
  • Five9 acquires Aceyus for $82 millionJones Day represented Five9, Inc. in its acquisition of 100% of the equity of Aceyus, Inc. for $82 million in cash.
  • Sumitomo acquires assets and rights related to lefamulin from NabrivaJones Day advised Sumitomo Pharma Co., Ltd. in the acquisition of assets from Nabriva Therapeutics plc and various wholly-owned subsidiaries. This acquisition includes assets from the U.S., Ireland, and Austria in support of the development, manufacture, marketing and commercialization of lefamulin in the People’s Republic of China, Hong Kong, Macau and Taiwan.
  • Astellas acquires Iveric bioJones Day advised Astellas Pharma Inc. in the $5.9 billion cash acquisition of Iveric bio, Inc., a science-driven biopharmaceutical company focused on the discovery and development of novel treatments for retinal diseases with significant unmet medical needs.
  • Ansys acquires DiakoptoJones Day advised Ansys in the acquisition of Diakopto, a provider of differentiated EDA solutions to accelerate integrated circuit (IC) development.
  • neoplas med and Niterra expand strategic partnershipJones Day advised Niterra (formerly NGK Spark Plug Co., LTD) in its growth investment in neoplas med GmbH in partnership with Pegasus Technology Ventures.
  • Horizon Global merges with First Brands GroupJones Day represented Horizon Global Corporation in its acquisition by First Brands Group, LLC, a global automotive parts manufacturer that serves the worldwide automotive aftermarket.
  • Meridian Bioscience agrees to be acquired by SD Biosensor and SJL Partners in $1.53 billion all-cash transactionJones Day advised Meridian Bioscience, Inc. in its $1.53 billion all-cash acquisition by SD Biosensor and SJL Partners.
  • VSE Aviation acquires Precision Fuel ComponentsJones Day advised VSE Aviation Services, LLC, a subsidiary of VSE Corporation (NASDAQ: VSEC), in the acquisition of Precision Fuel Components LLC.
  • Organon makes strategic investment in Claria MedicalJones Day advised Organon in the strategic investment in Claria Medical, Inc. a privately-held company developing an investigational medical device being studied for use during minimally invasive laparoscopic hysterectomy.
  • NGK SPARK PLUG announces strategic partnership with neoplas med GmbHJones Day advised NGK SPARK PLUG in its strategic partnership with neoplas med GmbH, a German medical company that specializes in innovative cold plasma jet technology.
  • NerdWallet acquires On The Barrelhead for $120 millionJones Day advised NerdWallet, Inc. (Nasdaq: NRDS), a platform that provides financial guidance to consumers and small- and mid-sized businesses, in its acquisition of On the Barrelhead, Inc. for total consideration of $120 million, consisting of approximately $70 million in cash and $50 million in NerdWallet Class A common stock.
  • National bank provides $95 million syndicated loan secured by multifamily properties located in CaliforniaJones Day represented a national bank, as administrative agent and lead lender, in connection with a $95 million syndicated loan secured by multifamily properties located in California.
  • Wells Fargo provides term loans totaling $257 million secured by portfolio of properties in North Carolina and TexasJones Day represented Wells Fargo Bank, National Association in connection with term loans totaling $257 million secured by a portfolio of properties located in North Carolina and Texas.
  • Hookit sells company to Kore SoftwareJones Day advised Hookit in the sale of 100% of Hookit’s stock to KORE Software, a portfolio company of Serent Capital.
  • Financial institution provides $50 million revolving credit facility secured by portfolio of commercial properties located in Illinois and New YorkJones Day represented a financial institution, as administrative agent and lead lender, in connection with a $50 million revolving credit facility secured by a portfolio of commercial properties located in Illinois and New York.
  • Financial institution provides $408 million syndicated loan secured by portfolio of industrial properties located in four Western statesJones Day represented a financial institution, as administrative agent and lead lender, in connection with a $408 million syndicated loan secured by a portfolio of industrial properties located in four Western states.
    •

    February 2024 White Paper

    2023 Securities Litigation Year in Review

    February 2022 White Paper

    2021 Securities Litigation Year in Review

    送信する前の注意事項：

    www.jonesday.comに掲載されている情報は、一般的な使用を目的としており、法的アドバイスを目的としたものではありません。このEmailを送信することにより、弁護士を含む専門家・依頼者の関係を構築することを意図するものではなく、このEmailの受領はそのような関係を構築するものではありません。当事務所に送信されたいかなる情報も、業務委託契約を結ばない限り、弁護士等が依頼者に対して守秘義務を負う機密事項として取り扱われることはありません。このEmailの送信者は以上の注意事項の内容を読み、理解したものと判断します。